A Multicenter, Randomized, Dose-Ranging, Double-Blind, Placebo-Controlled Study to Evaluate Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Moderate to Severe Platysmal Bands
Phase: PHASE2
Conditions: Platysmal Bands
Sponsor: Galderma R&D

A Multicenter, Randomized, Dose-Ranging, Double-Blind, Placebo-Controlled Study to 
Evaluate Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Moderate to Severe 
Platysmal Bands 
NCT Number: NCT04080882 
Protocol Document Date: 09Aug2019